Projecting direct medical costs and productivity benefits of improving access to advanced therapy for rheumatoid arthritis: a projection modelling study.
Chee Yoong FooNurul Azwani Nadia MansorShereen Suyin Ch'ngMollyza Mohd ZainPublished in: Journal of market access & health policy (2023)
Improving AT access for RA patients towards the aspirational target appeared to be feasible given the current health budget in Malaysia. Broader socio-economic consequences of productivity and income loss should be included as an important part of the policy consideration. The financial implication of different AT utilization mixes and the anticipated price adjustment will likely result in some cost saving to the health system.
Keyphrases
- rheumatoid arthritis
- healthcare
- mental health
- end stage renal disease
- public health
- climate change
- ejection fraction
- newly diagnosed
- disease activity
- chronic kidney disease
- peritoneal dialysis
- ankylosing spondylitis
- systemic lupus erythematosus
- health information
- interstitial lung disease
- risk assessment
- young adults
- magnetic resonance
- image quality
- human health
- health insurance